Delivery Order SPE2DB24D1201-SPE2DB24FJBAS

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $49,941.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has an ultimate completion date of August 6, 2024 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
This is a $18,046.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of the pharmaceutical product RINVOQ ER 15 MG TABLET, with a completion date of September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this product through an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $41,420.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of RINVOQ ER 30 MG TABLET UU 30S, a specialty medication, to support federal healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a $14,547.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a prescription pharmaceutical product, with an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $15,806.67, is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The award has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,066.48, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $6,942.03 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.58 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. It has an ultimate completion date of November 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The order, valued at $8,622.60, has a completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering the medication under a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $19,400.31 contract is for the supply of RINVOQ ER 15 MG TABLET, a prescription medication. The contract has an ultimate completion date of April 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBAS
    Delivery Order

This is a $16,177.97 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not utilize a set-aside designation.

Generated 11/19/24, 9:26 AM